| For: | Díaz del Arco C, Fernández Aceñero MJ, Ortega Medina L. Liquid biopsy for gastric cancer: Techniques, applications, and future directions. World J Gastroenterol 2024; 30(12): 1680-1705 [PMID: 38617733 DOI: 10.3748/wjg.v30.i12.1680] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v30/i12/1680.htm |
| Number | Citing Articles |
| 1 |
Jiangpeng Wei, Xinxin Wang, Danhong Dong, Yi Ru, Lubin Chen, Xin Cheng, Xiaohui Lv, Xin Guo. Extracellular vesicle-derived lncRNA-GC1 serves as a novel biomarker for predicting and monitoring the immunotherapeutic outcomes of patients with gastric cancer. BMC Medicine 2025; 23(1) doi: 10.1186/s12916-025-04270-0
|
| 2 |
V. A. Vshivkov, T. V. Polivanova, E. V. Kasparov. Biomarkers of precancerous diseases of the gastric mucosa in schoolchildren of ethnic populations of Tyva. Meditsinskiy sovet = Medical Council 2026; (1) doi: 10.21518/ms2026-001
|
| 3 |
Qian Wang, Siyi Jiang, Shuyu Zhai, Wenjia Yin, Yao Sun, Huifang Zhao, Ruiping Zhang. Advanced integrated SERS-based strategies for the early diagnosis of upper gastrointestinal cancers. Journal of Nanobiotechnology 2026; 24(1) doi: 10.1186/s12951-026-04844-x
|
| 4 |
Milena Carvalho Escaleira da Silva, Viviane Souza de Campos, Manoella Paiva Areas do Val da Silva, Valéria Pereira Ferrer. Liquid biopsy for the diagnosis, prognosis, and monitoring of common cancers: global and Brazilian perspectives. Oncologie 2026; 28(1) doi: 10.1515/oncologie-2025-0281
|
| 5 |
Francisco Cezar Aquino de Moraes, Danielle Queiroz Calcagno, Paulo Pimentel de Assumpção, Rommel Mario Rodríguez Burbano. Circulating tumor cells as prognostic biomarkers in advanced gastric cancer treated with CDC25B phosphatase inhibitors. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-26724-4
|
| 6 |
Marium Jahan, Ayesha Rubab, Mohsin Ali, Aneesa Sultan, Muhammad Zuhair, Muhammad Zakria, Jahangir Sarwar, Syed Waqas Hasan. Cancer Metastasis - Mechanism, Diagnosis, Prognosis and Targeted Therapy. Oncology 2025; 6 doi: 10.5772/intechopen.1008938
|
| 7 |
Vasile Bintintan, Claudia Burz, Irena Pintea, Adriana Muntean, Diana Deleanu, Iulia Lupan, Gabriel Samasca. The Importance of Extracellular Vesicle Screening in Gastric Cancer: A 2024 Update. Cancers 2024; 16(14) doi: 10.3390/cancers16142574
|
| 8 |
Rohan Ingawale, Sharad Chand, Rajesh Pradhan, Manoj Kushwaha, Rohit Singh. Liquid biopsy in Cancer Management. 2026; doi: 10.1016/B978-0-443-27496-1.00014-2
|
| 9 |
Kumudini Sahoo, Chandra Sekhar Barik, Sidhartha S. Kar. Liquid biopsy in Cancer Management. 2026; doi: 10.1016/B978-0-443-27496-1.00006-3
|
| 10 |
Supreet Kaur, Ankush Kumar, Rohit Bhatia, Diksha Choudhary, Rajwinder Kaur, Balakumar Chandrasekaran, Wael Abu Dayyih, Majd Nawras Maaita, Wafa Hourani. Potential biomarkers in early detection of gastric cancer. Frontiers in Pharmacology 2025; 16 doi: 10.3389/fphar.2025.1642927
|
| 11 |
Liao Zhang, Chen Huang, Ya-Qian Xu. Extracellular vesicle biomarkers in gastric cancer: Opportunities and challenges. Trends in Molecular Medicine 2026; doi: 10.1016/j.molmed.2026.06.010
|
| 12 |
Fashe Wang, Bai Li, Shangyin Li, Yan Tang, Tan Tao. Analysis of the clinical diagnostic efficacy of the novel serum markers lipase F, gastrokine 2 and the collagen X-type α1 chain in gastric cancer. Journal of Medical Biochemistry 2026; 45(2) doi: 10.5937/jomb0-59476
|
| 13 |
Francisco Cezar Aquino de Moraes, Gustavo Tadeu Freitas Uchôa Matheus, Luis Henrique Rios Moreira Rego, Erick Nelo Pedreira, Elizabeth Suchi Chen, Rommel Mario Rodriguez Burbano. Salivary biomarkers as a non-invasive diagnostic tool for gastric cancer: a systematic review and meta-analysis. Expert Review of Molecular Diagnostics 2026; doi: 10.1080/14737159.2026.2725657
|